tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

FHTX Stock Latest News

Foghorn Therapeutics Advances Drug Development in Oncology
Company AnnouncementsFoghorn Therapeutics Advances Drug Development in Oncology
4d ago
8K
FHTX
Foghorn Therapeutics initiated with a Buy at B. Riley
PremiumThe Fly
Foghorn Therapeutics initiated with a Buy at B. Riley
8d ago
FHTX
PRLD
Foghorn Therapeutics files $300M mixed securities shelf
PremiumThe Fly
Foghorn Therapeutics files $300M mixed securities shelf
14d ago
FHTX
Foghorn Therapeutics Sets 2025 Strategic Objectives
PremiumCompany Announcements
Foghorn Therapeutics Sets 2025 Strategic Objectives
25d ago
8K
FHTX
Foghorn Therapeutics highlights strategic objectives for 2025
PremiumThe Fly
Foghorn Therapeutics highlights strategic objectives for 2025
25d ago
FHTX
Foghorn Therapeutics Board Member Resignation Announced
PremiumCompany AnnouncementsFoghorn Therapeutics Board Member Resignation Announced
1M ago
8K
FHTX
Foghorn Therapeutics price target lowered to $4 from $9 at Morgan Stanley
Premium
The Fly
Foghorn Therapeutics price target lowered to $4 from $9 at Morgan Stanley
2M ago
FHTX
Foghorn Therapeutics price target lowered to $13 from $20 at H.C. Wainwright
Premium
The Fly
Foghorn Therapeutics price target lowered to $13 from $20 at H.C. Wainwright
2M ago
FHTX
Foghorn Therapeutics price target lowered to $14 from $18 at Jefferies
PremiumThe Fly
Foghorn Therapeutics price target lowered to $14 from $18 at Jefferies
2M ago
FHTX
Foghorn Therapeutics Advances Precision Oncology Pipeline
PremiumCompany Announcements
Foghorn Therapeutics Advances Precision Oncology Pipeline
2M ago
8K
FHTX
Foghorn to discontinue independent development of FHD-286 with decitabine in AML
PremiumThe Fly
Foghorn to discontinue independent development of FHD-286 with decitabine in AML
2M ago
LLY
FHTX
Foghorn Therapeutics (FHTX) Collaborates with Eli Lilly and Surpasses Q3 Expectations
PremiumMarket News
Foghorn Therapeutics (FHTX) Collaborates with Eli Lilly and Surpasses Q3 Expectations
3M ago
FHTX
Foghorn Therapeutics Reports Third Quarter Highlights
PremiumCompany AnnouncementsFoghorn Therapeutics Reports Third Quarter Highlights
3M ago
FHTX
Foghorn Therapeutics Advances Oncology Pipeline with New Trials
Premium
Company Announcements
Foghorn Therapeutics Advances Oncology Pipeline with New Trials
3M ago
8K
FHTX
Foghorn Therapeutics reports Q3 EPS (31c), consensus (44c)
Premium
The Fly
Foghorn Therapeutics reports Q3 EPS (31c), consensus (44c)
3M ago
FHTX
FHTX Earnings this Week: How Will it Perform?
PremiumPre-Earnings
FHTX Earnings this Week: How Will it Perform?
3M ago
FHTX
Foghorn Therapeutics Unveils Clinical Pipeline Progress
PremiumCompany Announcements
Foghorn Therapeutics Unveils Clinical Pipeline Progress
4M ago
8K
FHTX
Foghorn Therapeutics announces first patient dosed with FHD-909
PremiumThe Fly
Foghorn Therapeutics announces first patient dosed with FHD-909
4M ago
FHTX
Foghorn Therapeutics price target raised to $9 from $6 at Morgan Stanley
PremiumThe Fly
Foghorn Therapeutics price target raised to $9 from $6 at Morgan Stanley
5M ago
FHTX
Foghorn Therapeutics appoints Anna Rivkin as CBO
PremiumThe FlyFoghorn Therapeutics appoints Anna Rivkin as CBO
5M ago
BMY
FHTX
Foghorn Therapeutics initiated with a Buy at Jefferies
Premium
The Fly
Foghorn Therapeutics initiated with a Buy at Jefferies
5M ago
FHTX
Foghorn Therapeutics initiated with an Outperform at Evercore ISI
Premium
The Fly
Foghorn Therapeutics initiated with an Outperform at Evercore ISI
6M ago
FHTX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >